- cafead   May 15, 2024 at 11:32: AM
via As the biopharma industry explores the potential of artificial intelligence, use cases are quickly emerging. Companies are already looking to use generative AI—think ChatGPT—to optimize pharma R&D, from target discovery to drug development to regulatory approval to commercialization and postmarket pharmacovigilance.
article source
article source